Remedy Cell is a clinical stage biopharmaceutical company focused on the discovery and development of cell-derived, cell-free, breakthrough secretome therapies for areas of unmet need in fibrotic disease. 
Our proprietary technology has the potential to redefine fibrotic disease treatment, by enabling tissue regeneration and disease remission that will improve patients’ quality of life. Remedy Cell’s team consists of distinguished management, scientists, clinical experts, and international thought leaders who are working together to revolutionize the treatment of fibrotic diseases. 

Company’s lead product, RC-0315, for the treatment of Idiopathic Pulmonary Fibrosis (IPF) is currently evaluated under a phase Ib clinical trial.

REMEDY CELL Ltd.

Org chart

Teams

Offices